RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.

The ambitions of the National Prevention Agreement for smoking in adults can probably be realised through the proposed measures. This, however, does not apply to young people and pregnant women.

Recent years show a cautious improvement in the Dutch diet. The Dutch have started to eat more fruit and it seems to be heading in the right direction with vegetables.

“RIVM is committed to being innovative, and becoming a key player in citizen science is fully in line with that goal,” says Danielle Timmermans, Chief Science Officer for Risk Communication at RIVM

As of today, the RIVM website looks different than you are used to. This is because we are now using a new content management system and have implemented an enhanced design.

New data on antimicrobial resistance (AMR) in European countries is now available in the fourth annual report of the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAE

On 7 November 2018, Raymond Cointe, Director-General of INERIS and Hans Brug, Director-General of RIVM, signed a Framework Agreement. RIVM has been working with the French National Institute f

The prospects for future public health in the Netherlands are good. Our life expectancy is steadily increasing, and most people feel healthy and do not experience activity limitations.